BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8674074)

  • 1. Integrin VLA-2 (alpha2beta1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liver.
    Hangan D; Uniyal S; Morris VL; MacDonald IC; von Ballestrem C; Chau T; Schmidt EE; Chambers AF; Groom AC; Chan BM
    Cancer Res; 1996 Jul; 56(13):3142-9. PubMed ID: 8674074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin alpha2beta1 modulates EGF stimulation of Rho GTPase-dependent morphological changes in adherent human rhabdomyosarcoma RD cells.
    Leabu M; Uniyal S; Xie J; Xu YQ; Vladau C; Morris VL; Chan BM
    J Cell Physiol; 2005 Mar; 202(3):754-66. PubMed ID: 15481063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epitope on VLA-6 (alpha6beta1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver.
    Hangan D; Morris VL; Boeters L; von Ballestrem C; Uniyal S; Chan BM
    Cancer Res; 1997 Sep; 57(17):3812-7. PubMed ID: 9288792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of in vivo migratory function of alpha 2 beta 1 integrin in mouse liver.
    Ho WC; Heinemann C; Hangan D; Uniyal S; Morris VL; Chan BM
    Mol Biol Cell; 1997 Oct; 8(10):1863-75. PubMed ID: 9348529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
    Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
    J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
    Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
    Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains.
    Chan BM; Kassner PD; Schiro JA; Byers HR; Kupper TS; Hemler ME
    Cell; 1992 Mar; 68(6):1051-60. PubMed ID: 1547502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastine.
    Meyer N; Duensing S; Anastassiou G; Brevis Nunez F; Grosse J; Ganser A; Atzpodien J
    Anticancer Res; 1999; 19(2C):1509-12. PubMed ID: 10365134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent echovirus infection of mouse cells expressing the viral receptor VLA-2.
    Zhang S; Racaniello VR
    Virology; 1997 Sep; 235(2):293-301. PubMed ID: 9281509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.
    Duan H; Cheng L; Sun X; Wu Y; Hu L; Wang J; Zhao H; Lu G
    Thromb Haemost; 2006 Dec; 96(6):807-15. PubMed ID: 17139377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin alpha 2 beta 1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen.
    Vihinen P; Riikonen T; Laine A; Heino J
    Cell Growth Differ; 1996 Apr; 7(4):439-47. PubMed ID: 9052985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3).
    Takatsuki H; Komatsu S; Sano R; Takada Y; Tsuji T
    Cancer Res; 2004 Sep; 64(17):6065-70. PubMed ID: 15342388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
    Fritzsche J; Simonis D; Bendas G
    Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adhesion molecules and cancer metastasis].
    Ota I; Matsuura S
    Rinsho Byori; 1997 Jun; 45(6):528-33. PubMed ID: 9306710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion.
    Gardner H; Kreidberg J; Koteliansky V; Jaenisch R
    Dev Biol; 1996 May; 175(2):301-13. PubMed ID: 8626034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion molecule mechanisms mediating monocyte migration through synovial fibroblast and endothelium barriers: role for CD11/CD18, very late antigen-4 (CD49d/CD29), very late antigen-5 (CD49e/CD29), and vascular cell adhesion molecule-1 (CD106).
    Shang XZ; Lang BJ; Issekutz AC
    J Immunol; 1998 Jan; 160(1):467-74. PubMed ID: 9552005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence motifs in the integrin alpha 4 cytoplasmic tail required for regulation of in vivo expansion of murine lymphoma cells.
    Bittner M; Gosslar U; Luz A; Holzmann B
    J Immunol; 1998 Dec; 161(11):5978-86. PubMed ID: 9834079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow.
    Chen C; Mobley JL; Dwir O; Shimron F; Grabovsky V; Lobb RR; Shimizu Y; Alon R
    J Immunol; 1999 Jan; 162(2):1084-95. PubMed ID: 9916737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells.
    Wang MW; Consoli U; Lane CM; Durett A; Lauppe MJ; Champlin R; Andreeff M; Deisseroth AB
    Cell Growth Differ; 1998 Feb; 9(2):105-12. PubMed ID: 9486846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-erbA oncogene blocks expression of alpha2/beta1 integrin a normal inhibitor of erythroid progenitor proliferation.
    Mey A; Gandrillon O; McNagny KM; Clegg DO; Samarut J
    Oncogene; 2002 Apr; 21(18):2864-72. PubMed ID: 11973646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.